Abstract:Human islet amyloid polypeptide (hIAPP or amylin) is a causative agent in pancreatic amyloid deposits found in patients with type 2 diabetes. The aggregation of full-length hIAPP(1-37) into small oligomeric species is increasingly believed to be responsible for cell dysfunction and death. However, rat IAPP (rIAPP(1-37)), which differs from hIAPP in only six of 37 residues, loses its aggregation ability to form toxic amyloid species. Atomic details of the effect of sequence on the structure and toxicity between the amyloidogenic, toxic hIAPP peptide and the nonamyloidogenic, nontoxic rIAPP peptide remain unclear. Here, we probe sequence-induced differences in structural stability, conformational dynamics, and driving forces between different hIAPP and rIAPP polymorphic forms from monomer to pentamer using molecular dynamics simulations. Simulations show that hIAPP forms from trimer to pentamer exhibit high structural stability with well-preserved in-register parallel beta-sheet and the U-bend conformation. The hIAPP trimer appears to be a smallest minimal seed in solution. The stabilities of parallel hIAPP oligomers increase with the number of peptides. Conversely, replacement of hIAPP sequence by rIAPP sequence causes a significant loss of favorable interpeptide interactions in all rIAPP oligomers, destabilizing the C-terminal beta-sheet, turn conformation, and overall stability. A less beta-sheet-rich structure and a disturbed U-shaped topology exert a large energy penalty on the self-assemble of the rIAPP peptides into highly ordered, in-register beta-sheet-rich protofibrils and fibrils, which explains the nonamyloidogenic activity of rIAPP. Moreover, the absence of interior water within the U-turn region in the well-packed higher-order hIAPP oligomers, not in the poorly packed rIAPP oligomers, also stabilizes peptide association. This work provides atomic details of the sequence-structure relationship between the amyloidogenic hIAPP and its analogues such as the nonamyloidogenic rIAPP and some mutants, which could help in the development of novel therapeutic agents to block the formation of toxic hIAPP oligomeric species for type 2 diabetes.

Pristine and Hydroxylated Fullerenes Prevent the Aggregation of Human Islet Amyloid Polypeptide and Display Different Inhibitory Mechanisms

Influence of Fullerenol on Hiapp Aggregation: Amyloid Inhibition and Mechanistic Aspects.

Exploring The Influence Of Carbon Nanoparticles On The Formation Of Beta-Sheet-Rich Oligomers Of Iapp(22-28) Peptide By Molecular Dynamics Simulation

The inhibitory effect of hydroxylated carbon nanotubes on the aggregation of human islet amyloid polypeptide revealed by a combined computational and experimental study.

Destabilization of Human Islet Amyloid Polypeptide Fibrils by Charged Graphene Quantum Dots: A Molecular Dynamics Investigation with Implications for Nanomedicine

Stabilities and Structures of Islet Amyloid Polypeptide (IAPP22-28) Oligomers: from Dimer to 16-Mer.

The Molecular Mechanism of Fullerene-Inhibited Aggregation of Alzheimer's Β-Amyloid Peptide Fragment

Molecular Dynamics Simulations Reveal The Inhibitory Mechanism Of Dopamine Against Human Islet Amyloid Polypeptide (Hiapp) Aggregation And Its Destabilization Effect On Hiapp Protofibrils

Regulation of the Aggregation Behavior of Human Islet Amyloid Polypeptide Fragment by Titanocene Complexes

Hydrophobic/Hydrophilic Ratio of Amphiphilic Helix Mimetics Determines the Effects on Islet Amyloid Polypeptide Aggregation

Procyanidine Resists the Fibril Formation of Human Islet Amyloid Polypeptide.

Assembly behavior of amylin fragment hIAPP19-37 regulated by Au(III) complexes

Membrane Interactions of Hiapp Monomer and Oligomer with Lipid Membranes by Molecular Dynamics Simulations.

The Effects of A Series of Carbon Dots on Fibrillation and Cytotoxicity of Human Islet Amyloid Polypeptide

Effects of Hydroxylated Carbon Nanotubes on the Aggregation of Aβ16–22 Peptides: A Combined Simulation and Experimental Study

2D amyloid aggregation of human islet amyloid polypeptide at the solid-liquid interface

Effects of Carbon Nanoparticles on the Aggregation of Alzheimers Beta-Amyloid Peptide

Influence of Hydrophobicity on the Surface-Catalyzed Assembly of the Islet Amyloid Polypeptide

Recent computational studies of membrane interaction and disruption of human islet amyloid polypeptide: Monomers, oligomers and protofibrils

Regulation of oxaliplatin and carboplatin on the assembly behavior and cytotoxicity of human islet amyloid polypeptide

Comparative molecular dynamics study of human islet amyloid polypeptide (IAPP) and rat IAPP oligomers.